BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

Core Insights - BioNexus Gene Lab Corp. has successfully co-invested in Ascension Innovation Sdn Bhd through the Malaysia Co-Investment Fund (MyCIF), indicating strong confidence in AISB's strategic direction and potential [1][3] - AISB is the first recipient of investment under the Environmental & Social Impact (ESI) scheme, which aims to support small and medium enterprises (MSMEs) with impactful healthcare solutions [2] - The co-investment will enhance AISB's efforts in advancing the 'One Patient, One Record' initiative under Malaysia's National Electronic Medical Records (EMR) Plan, modernizing the healthcare infrastructure [3][4] Company Overview - BioNexus Gene Lab Corp. is focused on RNA-based genomic diagnostics and aims to improve global health outcomes through personalized medicine [5] - Ascension Innovation Sdn Bhd specializes in AI-driven healthcare technology solutions, committed to transforming healthcare through innovative practices [5] Financial Details - The total investment in this funding round amounts to RM1.7 million, approximately USD 390,000, highlighting the significance of sustainable healthcare innovations [4]